Barry, H, Hardiman, O, Healy, DG, Keogan, M, Moroney, J, Molnar, PP, et al.
Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry
2011; 199: 508–9.
Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, et al.
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol
2008; 7: 1091–8.
Lennox, BR, Coles, AJ, Vincent, A.
Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry
2012; 200: 92–4.
Irani, SR, Bera, K, Waters, P, Zuliani, L, Maxwell, S, Zandi, MS, et al.
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain
2010; 133: 1655–67.
Vincent, A, Bie, CG, Irani, SR, Waters, P.
Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol
2011; 10: 759–72.
Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, PB, McKenna, P, et al.
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol
2011; 258: 686–8.
Spinazzi, M, Argentiero, V, Zuliani, L, Palmieri, A, Tavolato, B, Vincent, A.
Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome. Neurology
2008; 71: 2008–10.
Kayser, MS, Kohler, CG, Dalmau, J.
Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry
2010; 167: 1039–50.
Stephan, KE, Friston, KJ, Frith, CD.
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull
2009; 35: 509–27.